N. Kaboré

Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus

H. Tinto, J. Ouédraogo, D. Chandramohan, 2021, PloS one.

Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin

H. Tinto, J. Ouédraogo, D. Chandramohan, 2020, The American journal of tropical medicine and hygiene.

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)

H. Tinto, G. Paradis, T. Kagoné, 2023, BMC Infectious Diseases.

Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration

F. Dabis, N. de Rekeneire, D. Ekouevi, 2020, HIV medicine.

APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa

S. Eymard-Duvernay, N. Meda, C. Kouanfack, 2021, Kidney international reports.

Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting

E. Delaporte, N. Meda, A. Cournil, 2019, BMC Nephrology.

WITHDRAWN: Balancing the genetic risk of APOL1 kidney disease variants.

Sophie Limou, N. F. Kaboré, N. Kaboré, 2019, Nephrologie & therapeutique.